Inspired by the need for new and better therapies for neurodegenerative diseases, researchers are exploring the link between uncontrolled inflammation within the brain and the brain's immune cells, known as microglia, which are emerging as a promising cellular target because of the prominent role they play in brain inflammation. The group highlights the design considerations and benefits of creating therapeutic nanoparticles for carrying pharmacological factors directly to the sites of the microglia.